Hyaluronoglucosaminidase clinical trials
Also written Hyaluronidase, Amphadase® and rHuPH20.
A group of medicines. Hyaluronidase (human recombinant) (69 studies) is counted on its own page; this page counts the studies that name Hyaluronoglucosaminidase itself.
How each study uses Hyaluronoglucosaminidase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Hyaluronoglucosaminidase studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 5 May 2004 · VITRASE · BLA 021640 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Medicines filed under Hyaluronoglucosaminidase
As reviewed, so not every one. Each counts its studies on its own page, not here.
Studies by the year they started
31 studies that test it; most in 2017 (4)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 23
Baxalta now part of Shire (5) · Assiut University (3) · Benha University (2) · Stanford University (2) · Cairo University (2) · Johns Hopkins University (1) · Misr University for Science and Technology (1) · Northwestern University (1)
Often tested with
Tested in the same studies.
Immunoglobulin G (7) · Lidocaine (2) · Immunoglobulins, Intravenous (2) · Daratumumab (2) · Dexmedetomidine (1) · Immunoglobulins (1) · Ceftriaxone (1) · Sodium Bicarbonate (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 3
Studies that test Hyaluronoglucosaminidase.
- Jun 2027Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALLPhase 2 · Eastern Cooperative Oncology Group
- Sep 2027Hyaluronidase Injections for Sclerodactyly in Patients With SclerodermaPhase 2 · Stanford University
- Sep 2027Hyaluronidase for Sclerodactyly in Systemic Sclerosis TrialEarly Phase 1 · Medical University of South Carolina
Studies
Open first, then newest update. How each study uses Hyaluronoglucosaminidase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 32
- Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALLRecruitingPhase 2Eastern Cooperative Oncology GroupNCT05289687Written as Daratumumab / Hyaluronidase Injection
- Hyaluronidase Injections for Sclerodactyly in Patients With SclerodermaNot yet recruitingPhase 2Stanford UniversityNCT07916324Written as hyaluronidase
- Hyaluronidase for Sclerodactyly in Systemic Sclerosis TrialNot yet recruitingEarly Phase 1Medical University of South CarolinaNCT07697274Written as Hyaluronidase (Hylenex)
- Perioperative Haemostasis, Procedure-Related Pain After Physiological or Pharmacological Modifications of Local Anaesthesia Around the EyesNot yet recruitingPhase 3Prince of Wales Hospital, Shatin, Hong KongNCT07734740Written as Hyaluronidase Injection
- Fentanyl Versus Ketorolac as an Adjuvant to Peribulbar Block for Anterior Segment SurgeriesRecruitingNot applicableCairo UniversityNCT07141589Written as Lidocaine + Bupivacaine + Hyaluronidase
- Effect of Hyaluronidase in Different Doses Added to Bupivacaine on TAB Block Quality During CSNot yet recruitingEarly Phase 1Benha UniversityNCT06839391Written as Hyaluronidase
- Reducing and Removing Hyaluronic Acid Filler With HyaluronidaseCompletedEarly Phase 1Northwestern UniversityNCT01722916Written as Hyaluronidase
- Peripheral Modulation of Muscle Stiffness and SpasticityActive, not recruitingPhase 2Johns Hopkins UniversityNCT03306615Written as Hyaluronidase
- A Study of TAK-881 and HyQvia in Healthy AdultsCompletedPhase 1TakedaNCT06895967Written as HyQvia
- Hyaluronidase Via LADD Scleroderma-induced MicrostomiaCompletedEarly Phase 1University of NebraskaNCT05995626Written as Hyaluronidase
- Effect of Adding Hyaluronidase to Bupivacaine in Transversus Abdominis Plane Block for Cesarean SectionCompletedNot applicableBenha UniversityNCT05671172Written as Hyaluronidase
- Wide-Awake Local Anesthesia No Tourniquet (WALANT) With Versus Without Hyaluronidase for Hand SurgeryActive, not recruitingPhase 2/3Misr University for Science and TechnologyNCT07000058Written as Hyaluronidase and Lidocaine 1% mixture
- The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic AnemiaCompletedPhase 1Dartmouth-Hitchcock Medical CenterNCT05004259Written as Daratumumab / Hyaluronidase Injection
- Hyaluronidase Assisted Subcutaneous InfusionCompletedPhase 3Shanghai Bao Pharmaceuticals Co., Ltd.NCT06604546Written as hyaluronidase
- Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDPCompletedPhase 3Baxalta now part of ShireNCT02955355Written as HYQVIA
- A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult ParticipantsCompletedPhase 1Baxalta now part of ShireNCT04578535Written as HYQVIA
- Dexmedetomidine Versus Hyalase Treatment of Carpal Tunnel SyndromeCompletedNot applicableAssiut UniversityNCT05280223Written as Hyalase
- Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD SubjectsCompletedPhase 3Baxalta now part of ShireNCT03277313Written as HYQVIA
- A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)CompletedPhase 3Baxalta now part of ShireNCT02549170Written as HYQVIA
- Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD SubjectsCompletedPhase 4Baxalta now part of ShireNCT03116347Written as HYQVIA
See all 32 studies that test Hyaluronoglucosaminidase →
Given beside what is tested · 5 — Hyaluronoglucosaminidase is usual care or a partner of the new treatment
- A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)RecruitingPhase 3TakedaNCT06747351Written as HYQVIA
- A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency DiseasesCompletedPhase 2/3TakedaNCT05755035Written as HYQVIA
- Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell LymphomaTerminatedPhase 2UNC Lineberger Comprehensive Cancer CenterNCT05498220Written as Hyaluronidase
- Nalbuphine as an Adjuvant to Local Anaesthetic Mixture in Peribulbar Cataract SurgeryCompletedNot applicableCairo UniversityNCT03436836Written as lidocaine, bupivacaine , hyaluronidase
- Efficacy and Safety of Adding Atracurium to Percaruncular Block for High Myopes Undergoing Cataract SurgeryCompletedPhase 4Kasr El Aini HospitalNCT03243500Written as hyaluronidase powder
As the comparator · 2 — what is tested is compared with Hyaluronoglucosaminidase
- Hyaluronidase in Intra-articular Steroid Injection Treating the Adhesive Capsulitis for ShoulderCompletedPhase 3Veterans Health Service Medical Center, Seoul, KoreaNCT04347733Written as Hyaluronidase Injection
- Efficacy of Hyalase Hydro-dissection in Treatment of Carpal Tunnel: Randomized Double Blind Controlled Clinical TrialCompletedNot applicableAssiut UniversityNCT03675295Written as Hyalase
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered1
- Hyaluronidase Injections for Sclerodactyly in Patients With SclerodermaNov 4, 2026NCT07916324
Codes
What other systems call Hyaluronoglucosaminidase · ClinicalTrials.gg INT007623
- RxNorm 5464One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 5464 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.